Cargando…
Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling
In the last 5 years inhibitors of the potassium channel K(V)1.3 have been shown to reduce neuroinflammation in rodent models of ischemic stroke, Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. At the systemic level these beneficial actions are mediated by a reduction in microgli...
Autores principales: | Fomina, Alla F., Nguyen, Hai M., Wulff, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781540/ https://www.ncbi.nlm.nih.gov/pubmed/33356832 http://dx.doi.org/10.1080/19336950.2020.1853943 |
Ejemplares similares
-
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
por: Chen, Yi‐Je, et al.
Publicado: (2017) -
Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke
por: Lee, Ruth D., et al.
Publicado: (2023) -
Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4‐mediated calcium entry in microglia
por: Nguyen, Hai M., et al.
Publicado: (2020) -
Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord
por: Zhang, Ting-Ting, et al.
Publicado: (2018) -
Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022)